great saphenous vein

(redirected from Saphenous vein grafts)
Also found in: Thesaurus, Medical.
Related to Saphenous vein grafts: saphenous veins
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.great saphenous vein - the longest vein in the bodygreat saphenous vein - the longest vein in the body; runs from foot to the groin where it joins the femoral vein
saphenous vein, vena saphena - either of two chief superficial veins of the leg that drain blood from the foot
References in periodicals archive ?
The Kips Bay Medical eSVS Mesh is designed to address the limitations of saphenous vein grafts used in coronary artery bypass graft (CABG) surgery.
Up to 25% of saphenous vein grafts occlude in the first postoperative year, and annual occlusion rates thereafter are l%-2% until year 5 and 4%-5% from years 5-10.
A coronary angiogram demonstrated that the LIMA and saphenous vein grafts were patent and not narrowed.
Brilakis said that some of the previous studies have indicated that patients receiving drug-eluting stents in saphenous vein grafts may not reduce the risk of re-narrowing and may be associated with increased risk of death.
Although arterial grafts have better long-term outcomes, venous grafts, specifically saphenous vein grafts (SVGs), are more readily available.
In an analysis that adjusted for several baseline differences, patients who were diagnosed with depression at entry had a 40% increased risk of having substantial atherosclerosis progression in their saphenous vein grafts, compared with patients who were not depressed at baseline, said Dr.
The TriActiv System, in its current indication, is designed to prevent heart attacks during the treatment of saphenous vein grafts (SVGs) in patients who previously received coronary bypass surgery, but now have blockages in the grafts.
The eSVS Mesh device is designed to prevent saphenous vein grafts from closing.
a company engaged in research, development, manufacturing and marketing of heterologous tissue covered stents, announced that the US Food and Drug Administration (FDA) has granted HUD (Humanitarian Use Device) designation to Over and Under(R) and Aneugraft(R) Pericardium Covered Stents for treatment of perforations and dissections of native coronary arteries and Saphenous Vein Grafts.
The relationship regarding postoperative inadequacies or occlusions of saphenous vein grafts with the degree of stenosis in the native coronary arteries is not clear.
After adjustment for baseline differences, patients depressed at entry had a 40% increased risk of having substantial atherosclerosis progression in their saphenous vein grafts, compared with patients who were not, which was significant, said Dr.